Vishat Diagnostics gets ICMR nod to supply Covid-19 antigen testing kit

PTI New Delhi | Updated on July 24, 2020 Published on July 24, 2020

Priced at ₹425, the kit can show results in 15 minutes

Mumbai-based firm Vishat Diagnostics on Friday said it has received approval from the Indian Council of Medical Research (ICMR) for supplying Covid-19 rapid testing antigen kit manufactured by Coris BioConcept.

The company plans to launch the testing kit named, ‘COVID-19 Ag Respi-Strip’, at a price of ₹425, Vishat Diagnostics said in a statement.

The kit tests for antibodies in users to determine whether they have had coronavirus infection in the past.

“With Covid-19 Ag Respi-Strip, we are bringing CE certified (allowed to sell in European Economic Area) and ICMR approved kits at affordable prices, which is also our company’s driving force for all other product lines,” Vishat Diagnostics MD Pratik Chaitala said.

At a time when India is touching its peak in daily numbers of cases, it becomes critical to rapidly increase testing, he added.

COVID-19 Ag Respi-Strip can show results in a span of 15 minutes, the statement said.

The kit has been developed by Belgium-based firm Coris BioConcept, and is used in several European countries and in North America, it added.

Follow us on Telegram, Facebook, Twitter Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 24, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.